High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder

<h3>Introduction</h3><p dir="ltr">Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by defects in two core domains, social/communication skills and restricted/repetitive behaviors or interests. There is no approved biomarker for ASD diagnosis,...

Full description

Saved in:

Bibliographic Details
Main Author:	Areej Mesleh (17149822) (author)
Other Authors:	Hanan Ehtewish (17149825) (author), Katie Lennard (5490287) (author), Houari B. Abdesselem (14152827) (author), Fouad Al-Shaban (17149828) (author), Julie Decock (44558) (author), Nehad M. Alajez (7397276) (author), Abdelilah Arredouani (10914455) (author), Mohamed M. Emara (9913215) (author), Omar Albagha (8977856) (author), Lawrence W. Stanton (6707191) (author), Sara A. Abdulla (13902015) (author), Jonathan M. Blackburnand (17149831) (author), Omar M. A. El-Agnaf (8809331) (author)
Published:	2023
Subjects:	Biological sciences Genetics Biomedical and clinical sciences Clinical sciences Neurosciences autism spectrum disorder autoantibodies profiling pathways biomarker
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder

Similar Items